[The mouth of patients with acromegaly].
Identifieur interne : 000101 ( Main/Exploration ); précédent : 000100; suivant : 000102[The mouth of patients with acromegaly].
Auteurs : Christine Cortet-Rudelli [France]Source :
- Presse medicale (Paris, France : 1983) [ 2213-0276 ] ; 2017.
Descripteurs français
- KwdFr :
- Acromégalie (complications), Acromégalie (diagnostic), Acromégalie (sang), Acromégalie (thérapie), Faciès (MeSH), Facteur de croissance IGF-I (métabolisme), Hormone de croissance humaine (sang), Humains (MeSH), Maladies de la bouche (diagnostic), Maladies de la bouche (sang), Maladies de la bouche (thérapie), Maladies des dents (diagnostic), Maladies des dents (sang), Maladies des dents (thérapie), Pronostic (MeSH), Valeurs de référence (MeSH).
- MESH :
- diagnostic : Acromégalie, Maladies de la bouche, Maladies des dents.
- métabolisme : Facteur de croissance IGF-I.
- sang : Acromégalie, Hormone de croissance humaine, Maladies de la bouche, Maladies des dents.
- thérapie : Acromégalie, Maladies de la bouche, Maladies des dents.
- Faciès, Humains, Pronostic, Valeurs de référence.
English descriptors
- KwdEn :
- Acromegaly (blood), Acromegaly (complications), Acromegaly (diagnosis), Acromegaly (therapy), Facies (MeSH), Human Growth Hormone (blood), Humans (MeSH), Insulin-Like Growth Factor I (metabolism), Mouth Diseases (blood), Mouth Diseases (diagnosis), Mouth Diseases (therapy), Prognosis (MeSH), Reference Values (MeSH), Tooth Diseases (blood), Tooth Diseases (diagnosis), Tooth Diseases (therapy).
- MESH :
- chemical , blood : Human Growth Hormone.
- blood : Acromegaly, Mouth Diseases, Tooth Diseases.
- complications : Acromegaly.
- diagnosis : Acromegaly, Mouth Diseases, Tooth Diseases.
- chemical , metabolism : Insulin-Like Growth Factor I.
- therapy : Acromegaly, Mouth Diseases, Tooth Diseases.
- Facies, Humans, Prognosis, Reference Values.
Abstract
Orofacial changes are frequent in acromegaly. Their evolution is slowly progressive. The lips (everted and thickened), the mandibular morphology (prognathism), the tongue (macroglossia), the soft palate and the uvula (increased and thickened), the parodontis (gingival hyperplasia, paradontitis), the teeth (increased interdental spaces, hypercementosis, increased dental mobility, multiple tooth loss) are concerned. Functional consequences are significant (obstructive sleep apnea syndrome, malocclusion, pain of the oral maxillofacial area, decrease of the quality of life). They are rarely noticed as the first symptoms of the disease and rarely responsible for the diagnosis of acromegaly because of a progressive development over a long period of time, and because of the low prevalence of the disease which can be unknown by dentists and dental surgeons. When patients are cured or well-controlled, abnormalities of soft tissues improve but are not always completely reversible and bone enlargement remain unchanged. If any corrective surgical procedures are to be performed, this should be carried out only after normalization of GH and IGF I levels.
DOI: 10.1016/j.lpm.2017.09.001
PubMed: 28943223
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[The mouth of patients with acromegaly].</title><author><name sortKey="Cortet Rudelli, Christine" sort="Cortet Rudelli, Christine" uniqKey="Cortet Rudelli C" first="Christine" last="Cortet-Rudelli">Christine Cortet-Rudelli</name><affiliation wicri:level="3"><nlm:affiliation>CHRU de Lille, hôpital Huriez, service d'endocrinologie, diabétologie et maladies métaboliques, rue Polonowski, 59037 Lille cedex, France. Electronic address: c.cortet@gmail.com.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>CHRU de Lille, hôpital Huriez, service d'endocrinologie, diabétologie et maladies métaboliques, rue Polonowski, 59037 Lille cedex</wicri:regionArea><placeName><region type="region" nuts="2">Hauts-de-France</region><region type="old region" nuts="2">Nord-Pas-de-Calais</region><settlement type="city">Lille</settlement></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:28943223</idno><idno type="pmid">28943223</idno><idno type="doi">10.1016/j.lpm.2017.09.001</idno><idno type="wicri:Area/Main/Corpus">000107</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000107</idno><idno type="wicri:Area/Main/Curation">000107</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000107</idno><idno type="wicri:Area/Main/Exploration">000107</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[The mouth of patients with acromegaly].</title><author><name sortKey="Cortet Rudelli, Christine" sort="Cortet Rudelli, Christine" uniqKey="Cortet Rudelli C" first="Christine" last="Cortet-Rudelli">Christine Cortet-Rudelli</name><affiliation wicri:level="3"><nlm:affiliation>CHRU de Lille, hôpital Huriez, service d'endocrinologie, diabétologie et maladies métaboliques, rue Polonowski, 59037 Lille cedex, France. Electronic address: c.cortet@gmail.com.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>CHRU de Lille, hôpital Huriez, service d'endocrinologie, diabétologie et maladies métaboliques, rue Polonowski, 59037 Lille cedex</wicri:regionArea><placeName><region type="region" nuts="2">Hauts-de-France</region><region type="old region" nuts="2">Nord-Pas-de-Calais</region><settlement type="city">Lille</settlement></placeName></affiliation></author></analytic><series><title level="j">Presse medicale (Paris, France : 1983)</title><idno type="eISSN">2213-0276</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Acromegaly (blood)</term><term>Acromegaly (complications)</term><term>Acromegaly (diagnosis)</term><term>Acromegaly (therapy)</term><term>Facies (MeSH)</term><term>Human Growth Hormone (blood)</term><term>Humans (MeSH)</term><term>Insulin-Like Growth Factor I (metabolism)</term><term>Mouth Diseases (blood)</term><term>Mouth Diseases (diagnosis)</term><term>Mouth Diseases (therapy)</term><term>Prognosis (MeSH)</term><term>Reference Values (MeSH)</term><term>Tooth Diseases (blood)</term><term>Tooth Diseases (diagnosis)</term><term>Tooth Diseases (therapy)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Acromégalie (complications)</term><term>Acromégalie (diagnostic)</term><term>Acromégalie (sang)</term><term>Acromégalie (thérapie)</term><term>Faciès (MeSH)</term><term>Facteur de croissance IGF-I (métabolisme)</term><term>Hormone de croissance humaine (sang)</term><term>Humains (MeSH)</term><term>Maladies de la bouche (diagnostic)</term><term>Maladies de la bouche (sang)</term><term>Maladies de la bouche (thérapie)</term><term>Maladies des dents (diagnostic)</term><term>Maladies des dents (sang)</term><term>Maladies des dents (thérapie)</term><term>Pronostic (MeSH)</term><term>Valeurs de référence (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Human Growth Hormone</term></keywords><keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>Acromegaly</term><term>Mouth Diseases</term><term>Tooth Diseases</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Acromegaly</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Acromegaly</term><term>Mouth Diseases</term><term>Tooth Diseases</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Acromégalie</term><term>Maladies de la bouche</term><term>Maladies des dents</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Insulin-Like Growth Factor I</term></keywords><keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Facteur de croissance IGF-I</term></keywords><keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Acromégalie</term><term>Hormone de croissance humaine</term><term>Maladies de la bouche</term><term>Maladies des dents</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Acromegaly</term><term>Mouth Diseases</term><term>Tooth Diseases</term></keywords><keywords scheme="MESH" qualifier="thérapie" xml:lang="fr"><term>Acromégalie</term><term>Maladies de la bouche</term><term>Maladies des dents</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Facies</term><term>Humans</term><term>Prognosis</term><term>Reference Values</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Faciès</term><term>Humains</term><term>Pronostic</term><term>Valeurs de référence</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Orofacial changes are frequent in acromegaly. Their evolution is slowly progressive. The lips (everted and thickened), the mandibular morphology (prognathism), the tongue (macroglossia), the soft palate and the uvula (increased and thickened), the parodontis (gingival hyperplasia, paradontitis), the teeth (increased interdental spaces, hypercementosis, increased dental mobility, multiple tooth loss) are concerned. Functional consequences are significant (obstructive sleep apnea syndrome, malocclusion, pain of the oral maxillofacial area, decrease of the quality of life). They are rarely noticed as the first symptoms of the disease and rarely responsible for the diagnosis of acromegaly because of a progressive development over a long period of time, and because of the low prevalence of the disease which can be unknown by dentists and dental surgeons. When patients are cured or well-controlled, abnormalities of soft tissues improve but are not always completely reversible and bone enlargement remain unchanged. If any corrective surgical procedures are to be performed, this should be carried out only after normalization of GH and IGF I levels.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28943223</PMID><DateCompleted><Year>2017</Year><Month>10</Month><Day>13</Day></DateCompleted><DateRevised><Year>2017</Year><Month>10</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2213-0276</ISSN><JournalIssue CitedMedium="Internet"><Volume>46</Volume><Issue>9</Issue><PubDate><Year>2017</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Presse medicale (Paris, France : 1983)</Title><ISOAbbreviation>Presse Med</ISOAbbreviation></Journal><ArticleTitle>[The mouth of patients with acromegaly].</ArticleTitle><Pagination><MedlinePgn>831-837</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0755-4982(17)30375-5</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.lpm.2017.09.001</ELocationID><Abstract><AbstractText>Orofacial changes are frequent in acromegaly. Their evolution is slowly progressive. The lips (everted and thickened), the mandibular morphology (prognathism), the tongue (macroglossia), the soft palate and the uvula (increased and thickened), the parodontis (gingival hyperplasia, paradontitis), the teeth (increased interdental spaces, hypercementosis, increased dental mobility, multiple tooth loss) are concerned. Functional consequences are significant (obstructive sleep apnea syndrome, malocclusion, pain of the oral maxillofacial area, decrease of the quality of life). They are rarely noticed as the first symptoms of the disease and rarely responsible for the diagnosis of acromegaly because of a progressive development over a long period of time, and because of the low prevalence of the disease which can be unknown by dentists and dental surgeons. When patients are cured or well-controlled, abnormalities of soft tissues improve but are not always completely reversible and bone enlargement remain unchanged. If any corrective surgical procedures are to be performed, this should be carried out only after normalization of GH and IGF I levels.</AbstractText><CopyrightInformation>Copyright © 2017 Elsevier Masson SAS. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cortet-Rudelli</LastName><ForeName>Christine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>CHRU de Lille, hôpital Huriez, service d'endocrinologie, diabétologie et maladies métaboliques, rue Polonowski, 59037 Lille cedex, France. Electronic address: c.cortet@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>fre</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><VernacularTitle>La bouche de l’acromégale.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2017</Year><Month>09</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Presse Med</MedlineTA><NlmUniqueID>8302490</NlmUniqueID><ISSNLinking>0755-4982</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C583557">IGF1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>12629-01-5</RegistryNumber><NameOfSubstance UI="D019382">Human Growth Hormone</NameOfSubstance></Chemical><Chemical><RegistryNumber>67763-96-6</RegistryNumber><NameOfSubstance UI="D007334">Insulin-Like Growth Factor I</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000172" MajorTopicYN="N">Acromegaly</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019066" MajorTopicYN="Y">Facies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019382" MajorTopicYN="N">Human Growth Hormone</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007334" MajorTopicYN="N">Insulin-Like Growth Factor I</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009059" MajorTopicYN="N">Mouth Diseases</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012016" MajorTopicYN="N">Reference Values</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014076" MajorTopicYN="N">Tooth Diseases</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>9</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>10</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>9</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28943223</ArticleId><ArticleId IdType="pii">S0755-4982(17)30375-5</ArticleId><ArticleId IdType="doi">10.1016/j.lpm.2017.09.001</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>France</li></country><region><li>Hauts-de-France</li><li>Nord-Pas-de-Calais</li></region><settlement><li>Lille</li></settlement></list><tree><country name="France"><region name="Hauts-de-France"><name sortKey="Cortet Rudelli, Christine" sort="Cortet Rudelli, Christine" uniqKey="Cortet Rudelli C" first="Christine" last="Cortet-Rudelli">Christine Cortet-Rudelli</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SuicidDentistV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000101 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000101 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SuicidDentistV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:28943223
|texte= [The mouth of patients with acromegaly].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:28943223" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a SuicidDentistV1
| This area was generated with Dilib version V0.6.39. |  |